Atorvastatin-loaded nanostructured lipid carriers (NLCs): strategy to overcome oral delivery drawbacks

Atorvastatin (AT) is a widely used lipid-regulating drug to reduce cholesterol and triglycerides. Its poor aqueous solubility and hepatic metabolism require development of drug delivery systems able to improve its solubility and bypass hepatic effect. For this purpose, atorvastatin nanostructured li...

Descripción completa

Detalles Bibliográficos
Autores principales: Elmowafy, Mohammed, Ibrahim, Hany M., Ahmed, Mohammed A., Shalaby, Khaled, Salama, Ayman, Hefesha, Hossam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8241136/
https://www.ncbi.nlm.nih.gov/pubmed/28617150
http://dx.doi.org/10.1080/10717544.2017.1337823

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8241136/
https://www.ncbi.nlm.nih.gov/pubmed/28617150
http://dx.doi.org/10.1080/10717544.2017.1337823

Ejemplares similares